Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/29931
Title: SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).
Authors: 
Keywords: 
Mesh: 
Issue Date: Jan-2018
Citation: Clin Transl Oncol.2018 Jan;(20)1:22-28
Abstract: Glioblastoma (GB) is the most common brain malignancy and accounts for over 50% of all high-grade gliomas. Radiotherapy (RT) with concomitant and adjuvant temozolomide (TMZ) chemotherapy is the current standard of care for patients with newly diagnosed GB up to age 70. Recently, a new standard of care has been adopted for elderly patients (≥ 65 years) based on short course of RT and TMZ. Several clinically relevant molecular markers that assist in diagnosis and prognosis have recently been identified. The treatment for recurrent GB is not well defined, and decision-making is usually based on prior strategies as well as several clinical and radiological factors. The presence of neurologic deficits and seizures can significantly impact quality of life.
PMID: 29086250
URI: https://hdl.handle.net/20.500.12530/29931
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC5785619.pdf458.96 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.